Colorectal Cancer Coalition

Colon Cancer Alliance Rings the NASDAQ Bell

In celebration of Colorectal Cancer Awareness Month, members of the Colon Cancer Alliance rang the closing bell for NASDAQ on March 2.

CCA CEO Andrew Spiegel was joined by staff, board members, and colon cancer survivors for the closing ceremony.

Watch a clip of the ceremony on Facebook.c

Andy Spiegel said,

We’re excited that the NASDAQ recognized March as Colon Cancer Awareness Month in such a public manner. Colorectal cancer is the second leading cause of cancer death in the U.S., affecting 1 in 19 Americans. The disease is almost entirely preventable through screening, yet only about half of those who should be tested actually get screened. 50,000 Americans die each year from colorectal cancer and we are now at a critical juncture that requires greater public awareness and support — NASDAQ’s help in increasing awareness was invaluable.

This news article was originally posted on March 9th, 2010 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on March 9th, 2010
Tags: colorectal cancer awareness, NASDAQ

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Name Email (hidden) URL Comments (Basic HTML is allowed - a href, strong, em, blockquote)